01:48 PM EDT, 05/29/2026 (MT Newswires) -- Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.9%.

The iShares Biotechnology ETF (IBB) rose 0.3%.

In corporate news, AstraZeneca's ( AZN ) Alexion Rare Disease unit said Friday that a phase 3 program evaluating anselamimab in light chain amyloidosis did not meet its primary endpoint in the overall patient population. Shares were fractionally lower.

Becton, Dickinson ( BDX ) said it has resumed US shipments of ChloraPrep after completing additional assessments and implementing final release testing. Shares were little changed.

Replimune ( REPL ) shares surged 85% after the firm said Friday it will resubmit its biologics license application for vusolimogene oderparepvec for advanced melanoma in the coming days.